India’s Price Controls To Expand To All Essential Drugs; Impact On MNCs More Severe Than Indian Firms
This article was originally published in PharmAsia News
Executive Summary
Long winded discussions culminated in a proposed policy framework that may impact margins of larger brands, but the industry is not yet complaining.